Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
about
Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogeneAntibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine SecretionMetastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer.A novel Markov Blanket-based repeated-fishing strategy for capturing phenotype-related biomarkers in big omics dataOncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinomaVEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2CA role of autophagy in PTP4A3-driven cancer progression.Phosphatase of regenerating liver: a novel target for cancer therapy.Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD-negative acute myeloid leukemia.Protein tyrosine phosphatase 4A2 expression predicts overall and disease-free survival of human breast cancer and is associated with estrogen and progestin receptor status.Expression of phosphatase of regenerating liver family genes during embryogenesis: an evolutionary developmental analysis among Drosophila, amphioxus, and zebrafishIntegrative analysis of prostate cancer aggressiveness.Correlation between Liver Metastases and the Level of PRL-3 mRNA Expression in Patients with Primary Colorectal Cancer.Tissue-specific alterations of PRL-1 and PRL-2 expression in cancerThe prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer.Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cellsPhosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness.Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease.Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancerEnzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.Phosphatase of regenerating liver 2 (PRL2) deficiency impairs Kit signaling and spermatogenesis.Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms' tumor.Molecular mechanisms of the PRL phosphatases.Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.PRL-2 increases Epo and IL-3 responses in hematopoietic cellsPRL-3 overexpression in epithelial cells is induced by surrounding stromal fibroblasts.High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma.Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.
P2860
Q24309666-A57CFFDD-1B00-4FCA-9EF1-9CC8EC82F2DCQ24318418-1D51901D-C360-40D4-87BD-B4076C8C5153Q27326713-ECEA0B00-5C4F-4E8D-8818-FF446AD84CCFQ28469321-18F1E7D1-BE99-49FB-8832-2C7552711ADFQ30371232-C8FCEFA1-D8EE-4AA3-9508-A0C94F8B87E2Q30420119-76965F45-6790-49A5-8AE1-42873CAC97CAQ31055003-A46B7E19-B3B3-4266-B5DD-3FB53C75F58FQ33977014-3EBB041A-15FB-44FF-AD4C-C2E80439979AQ34071838-6AE63738-57D6-4E1E-812E-6EC91F415D99Q34344700-7AB21227-6EEA-4C9B-8928-65271D436E6EQ34437541-86FD7391-A58B-4910-A150-BB49CD353277Q34455621-C47689CF-7622-4CCA-8D41-F30F61408614Q34507306-89B5466B-42FD-4CB0-93DB-C4075187708AQ34660130-4EFCC7FF-3F37-4EC3-BC3B-C073F97F5374Q34704624-77FCE5DA-C01A-49AC-8E46-F8200D037475Q34787486-96FAAB91-1778-41E7-91AA-D535A3919068Q35555652-27968FC6-F71B-4AA2-AC1F-81E7F3D6C20AQ35747480-E7646057-1E4E-4EC4-B576-93141A99B064Q35867697-5ED064F6-A8C9-4EC2-B01F-C0300DE2765BQ36384761-37A09F45-22E0-43FF-B3E9-22EEE62BC4CCQ36918028-C6BD5D0B-7D76-40D4-B078-D15CE9D71C1FQ36977592-B4BD08C9-1001-457F-A052-994215344BC1Q37094068-94742692-B4C3-4C3A-AAB1-F4F10BA9066FQ37149601-EA6E4258-33B8-4CF0-9349-62600DA49D26Q37382038-862C947B-4CE7-448D-B840-095F829CBB62Q37426883-0574F3DB-0498-42A9-9D6E-B0E5FA609912Q37472041-DD5FA0A8-35FA-45DE-A5C0-E3F0C6A8E0B2Q37563586-BDE9668C-7087-49D0-A17B-D4116C44C1CBQ37587207-82927E99-F391-4D48-AE2F-D71814B65D66Q37993157-4654D292-E6CD-4ECC-8EFF-34BA30E44863Q38644355-90DCAAF3-A47B-4CE2-A19C-C2957B57FBCFQ38763126-12052B3A-DDDE-45E3-AF68-5122967FC937Q38786529-FB1D7BE6-64EE-4583-BA77-45F8AB3082EEQ39728196-8957F08A-EE31-44FB-A5DF-CFACF96FCF7DQ39827482-9FB63EF4-0484-4D44-AF20-1BFD2E91307DQ39916955-B643AFB4-47BF-44F9-AA19-5BE623676753Q41127993-B843F9F5-7121-41F7-B0BC-CBB00966672FQ43678272-695710B6-94BB-4537-ABAF-9D04520B3188Q44320637-094FCF96-89A4-4B37-9ABB-BA8A8AB41937Q47123783-C20B45D9-A535-4F1D-A489-BB82B52F0C8B
P2860
Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@ast
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@en
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@nl
type
label
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@ast
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@en
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@nl
prefLabel
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@ast
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@en
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@nl
P2093
P2860
P356
P1476
Expression and prognostic impa ...... -2, and PRL-3 in breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603261
P407
P50
P577
2006-07-11T00:00:00Z
P5875
P6179
1006504745